CYTOMEGALOVIRUS-DRIVEN ADAPTIVE-LIKE NATURAL KILLER CELL EXPANSIONS ARE UNAFFECTED BY CONCURRENT CHRONIC HEPATITIS VIRUS INFECTIONS

Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus Infections

Adaptive-like expansions of natural killer (NK) cell subsets are known to occur in response to human cytomegalovirus (CMV) infection.These expansions are typically made up of NKG2C+ NK cells with particular killer-cell immunoglobulin-like receptor (KIR) expression patterns.Such NK cell expansion patterns are also seen in patients with viral hepatit

read more


The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients

Abstract Background The Anti-Clot Treatment Scale (ACTS) is a 15-item patient-reported instrument of satisfaction with anticoagulant treatment.It includes a 12-item ACTS Burdens scale and a 3-item ACTS Benefits scale.Its role in clinical trials and other settings should be supported by evidence that it is both clinically meaningful and scientifical

read more